128 related articles for article (PubMed ID: 6838676)
1. Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity.
Zeller J; Weissbarth E; Baruth B; Mielke H; Deicher H
Arthritis Rheum; 1983 Apr; 26(4):532-40. PubMed ID: 6838676
[TBL] [Abstract][Full Text] [Related]
2. [Thrombocyte function and thrombocyte-associated immunoglobulins in patients with systemic lupus erythematosus and chronic polyarthritis].
Horn A; Avenarius HJ; Deicher H
Klin Wochenschr; 1990 May; 68(9):460-5. PubMed ID: 2355725
[TBL] [Abstract][Full Text] [Related]
3. Platelet-associated IgG in idiopathic glomerulonephritis and the nephritis of systemic lupus erythematosus.
Bennett A; Frampton G; Cameron JS
Br J Haematol; 1986 Apr; 62(4):695-703. PubMed ID: 3964562
[TBL] [Abstract][Full Text] [Related]
4. [The induction of an acquired storage pool deficiency of the thrombocytes by IgG antibodies in systemic lupus erythematosus and chronic polyarthritis].
Falke S; Avenarius HJ; Deicher H
Z Rheumatol; 1990; 49(2):70-6. PubMed ID: 2349839
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and platelet IgG in various diseases.
Puram V; Giuliani D; Morse BS
Clin Exp Immunol; 1984 Dec; 58(3):672-6. PubMed ID: 6509798
[TBL] [Abstract][Full Text] [Related]
6. Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.
Weissbarth E; Baruth B; Mielke H; Liman W; Deicher H
Rheumatol Int; 1982; 2(2):67-73. PubMed ID: 6217534
[TBL] [Abstract][Full Text] [Related]
7. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
[TBL] [Abstract][Full Text] [Related]
8. Platelet-bound IgG in systemic lupus erythematosus with and without thrombocytopenia.
Mulshine J; Lucas FV; Clough JD
J Immunol Methods; 1981; 45(3):275-81. PubMed ID: 7288196
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet serotonin levels in systemic lupus erythematosus.
Meyerhoff J; Dorsch CA
Arthritis Rheum; 1981 Dec; 24(12):1495-1500. PubMed ID: 6459785
[TBL] [Abstract][Full Text] [Related]
10. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
11. SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.
Yeatts RP; Turner R; Collins R; Kaufmann J; Mashburn H
Ann Rheum Dis; 1978 Oct; 37(5):421-7. PubMed ID: 718274
[TBL] [Abstract][Full Text] [Related]
12. Decreased platelet counts and decreased platelet serotonin in poststreptococcal nephritis.
Mezzano S; Kunick M; Olavarría F; Ardiles L; Aranda E; Mezzano D
Nephron; 1995; 69(2):135-9. PubMed ID: 7723894
[TBL] [Abstract][Full Text] [Related]
13. Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus.
Kasai N; Parbtani A; Cameron JS; Yewdall V; Shepherd P; Verroust P
Clin Exp Immunol; 1981 Jan; 43(1):64-72. PubMed ID: 7249395
[TBL] [Abstract][Full Text] [Related]
14. Elevated platelet-associated IgG in SLE patients due to anti-platelet autoantibody: differentiation between autoantibodies and immune complexes by ether elution.
Kurata Y; Hayashi S; Kosugi S; Kashiwagi H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Br J Haematol; 1993 Dec; 85(4):723-8. PubMed ID: 7918036
[TBL] [Abstract][Full Text] [Related]
15. Serum factors releasing serotonin from normal platelets: relation to the manifestations of systemic lupus erythematosus.
Ginsberg MH; O'Malley M
Ann Intern Med; 1977 Nov; 87(5):564-7. PubMed ID: 921084
[TBL] [Abstract][Full Text] [Related]
16. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.
Cloutier N; Allaeys I; Marcoux G; Machlus KR; Mailhot B; Zufferey A; Levesque T; Becker Y; Tessandier N; Melki I; Zhi H; Poirier G; Rondina MT; Italiano JE; Flamand L; McKenzie SE; Cote F; Nieswandt B; Khan WI; Flick MJ; Newman PJ; Lacroix S; Fortin PR; Boilard E
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1550-E1559. PubMed ID: 29386381
[TBL] [Abstract][Full Text] [Related]
17. Platelet Fc receptor. Increased expression in myeloproliferative disease.
Moore A; Nachman RL
J Clin Invest; 1981 Apr; 67(4):1064-71. PubMed ID: 6937475
[TBL] [Abstract][Full Text] [Related]
18. [Anti-platelet antibodies in patients with autoimmune disorders].
Kurata Y
Rinsho Ketsueki; 1993 May; 34(5):593-8. PubMed ID: 8315830
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.
Samuel H; Nardi M; Karpatkin M; Hart D; Belmont M; Karpatkin S
Br J Haematol; 1999 Jun; 105(4):1086-91. PubMed ID: 10554825
[TBL] [Abstract][Full Text] [Related]
20. Platelet lactate dehydrogenase activity in systemic lupus erythematosus: correlation with anticardiolipin antibodies.
Zoli A; Zappacosta B; Altomonte L; De Sole P; Caricchio R; Pellegrino M; Mirone L; Giardina B; Magaro M
J Rheumatol; 1995 Apr; 22(4):649-53. PubMed ID: 7791157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
